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Introduction: To analyze the diagnostic accuracy of MRI in patients undergoing
parietal and occipital lobe epilepsy surgery.
Methods: In a retrospective study, we analyzed MRI scans and neuropathology reports
of 42 patients who had undergone resective epilepsy surgery in the parietal and
occipital lobe between 1998 and 2003. We evaluated, whether lesions were precisely
characterized by MRI and whether lesion characterization allowed to estimate
postsurgical seizure outcome.
Results: Within the categories epilepsy associated tumors, focal cortical dysplasias,
vascular malformations, scarring, and others, MRI was concordant with histopathology
in 36 of 42 (86%) lesions. Among the discordant lesions, one lesion was re-classified
following MRI—histopathology synopsis, another two lesions represented new tumor
entities (angiocentric neuroepithelial tumor, isomorphic astrocytoma) which have
been described recently. Seizure freedom (Engel class I) one year following surgery
was achieved in 25 patients (60%). Seizure outcomewas different for lesion categories
(Engel class I: epilepsy associated tumors, 62%; focal cortical dysplasias, 71%; vascular
malformations, 75%; scarring, 40%), and was unchanged if no lesion was found on
preoperative MRI.
Conclusion: If MRI and histopathology are discordant, not only the MRI findings may be
debatable. MRI lesion detection is important, since chance of seizure freedom is low if
no lesion is detected.
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Parietal andoccipital lobe seizures are relatively rare
accounting for less than 10% of all partial seizures
reported from comprehensive surgical series. In par-
ietal lobe seizures, the most common subjective
sensations or auras are paresthesias, dysesthesias
or pain; additional parietal lobe symptoms include
sexual sensations, apraxias, and disturbances of body
image. Conversely, much of the parietal lobe is clini-
cally silent in terms of seizure manifestation. Objec-
tive parietal lobe seizure manifestations (e.g.
dominant parietal lobe: disturbances of language
functions) are rare and most objective manifesta-
tions reflect seizure spread outside the parietal lobe.
The majority of patients with occipital lobe seizures
describe visual phenomena (elementary hallucina-
tions, illusions including metomorphopsia and dys-
chromatopsia, viual loss) as the initial ictal
manifestation.1 However, these phenomenamay also
be elicited in temporo-occipital and anterior tem-
poro-mesial structures.2 Moreover, ictal discharges
originating in the occipital lobe seizures usually
rapidly spread into anterior areas.3
Localizing of the seizure onset was difficult and
frequently erroneous in the pre-MRA area,4 and
magnetic resonance imaging (MRI) has become an
important tool for localization of the seizure onset
zone. Congruity of a MRI lesion, ictal surface EEG
focus, and seizure semiology may allow epilepsy
surgery without further invasive diagnostic proce-
dures. In patients, in whom seizure semiology and
scalp EEG recordings are inconclusive, a MRI lesion
may generate a hypothesis for intracranial elec-
trode implantation. Whether a lesion is detected
by MRI, depends on the quality of the MRI scan and
the expertise of the MRI reader.5 When a lesion is
detected, the risk of invasive presurgical work-up
and potential epilepsy surgery must be weighted
against the estimated chance of seizure freedom
following surgery. In this context, two questions are
of interest: (1) Are the lesions correctly character-
ized by MRI? (2) Does the seizure outcome following
surgery depend on the type of the MRI lesion?
In the present study, we retrospectively analyzed
the MRI and neuropathology reports of patients with
parietal and occipital lobe epilepsies who had under-




The study group comprised all patients with drug-
resistant parietal and occipital lobe epilepsies whohad a high resolution MRI and were operated follow-
ing presurgical work-up at the University of Bonn
Medical Center between 1998 and December 2003.
MRI
MRI was performed using 1.5 or 3 Tesla systems
(Gyroscan ACS-NT, Gyroscan NT-Intera, Gyroscan
Intera, Gyroscan 3 T Intera, Gyroscan 3T Achieva,
Philips Medical Systems, Best, The Netherlands)
according to a standardized protocol that has been
described previously.6,7 In brief, we first acquired a
sagittally oriented 3D-T1-weighted gradient echo
sequence with 1 mm3 isotropic voxels. Displaying
the sagittal 3D-T1-weighted gradient echo
sequence, the next two sequences, an axial FLAIR
fast spin echo and an axial T2-weighted fast spin
echo sequence with a slice thickness of 5 mm and an
interslice gap of 1 mm were angulated either along
the length axis of the hippocampus or the anterior
comissure—posterior comissure-line (a.c.—p.c.-
line). How the slices were angulated, depended
on seizure semiology and EEG findings, and was
decided after patient’s history was reported from
the transferring epileptologist.
Next, coronal FLAIR fast spin echo (slice thickness
3 mm), coronal T2-weighted fast spin echo (slice
thickness 2 mm), and coronal T1-weighted inversion
recovery sequences (slice thickness 5 mm, interslice
gap 0.5 mm) were obtained. If axial sequences were
angulated along the hippocampal length axis, slice
orientation was perpendicular to axial slices. If axial
sequences were angulated along the a.c.—p.c.-line,
coronal FLAIR sequence was tilted along the brain
stem, but the coronal T2-weighted sequence per-
pendicular on hippocampal length axis. If a lesion
suggestive for a tumour was detected, axial and/or
coronal T1-weighted spin echo sequences (slice
thickness 5 mm, interslice gap 1 mm) before and
following Gd-DTPA injection were acquired.
Further pre-surgical work-up
Further pre-surgical work-up included vidoe-EEG-
monitoring in all patients, whereas other investiga-
tions (ictal and interictal SPECT, Subtraction ictal
SPECT co-registered to MRI (SISCOM), PET, depth
electrodes, subdural grid or strip electrodes) were
performed as deemed necessary in each patient.8
Surgery
Surgical approaches targeted to resect the epilep-
togenic zonewhile sparing eloquent cortex. The size
and location of the epileptogenic zone was usually
determined following the implantation of subdural
610 H. Urbach et al.grid electrodes in 32 patients. Extended lesionec-
tomies were performed in 34 patients.
Histopathology
Surgical specimens submitted for neuropathologi-
cal evaluation were microscopically analyzed using
haematoxylin—eosin (HE), haematoxylin—eosin—
luxol-fast-blue (HE—LFB) and Nissl staining. Immu-
nohistochemical studies included reactions with a
monoclonal antibody directed against Vimentin
(V9, Dako), polyclonal antibodies directed against
glial fibrillary acid protein (GFAP), a monoclonal
antibody directed against human neurofilament
protein (2F11, Dako), a monoclonal antibody direc-
ted against neuronal specific enolase (NSE), a
monoclonal antibody to synaptophysin (SY 38,
Dako), a monoclonal antibody directed against
Ki67 (MIB1, Dako), and a monoclonal antibody
directed against CD 34 (QBend 10, Immunotech)
using standard protocols and the avidin-biotin-per-
oxidase complex with diaminobenzidine as chro-
mogen.9
Postsurgical outcome
Patients were re-examined at routine intervals
three months, six months and one year following
surgery. Seizure outcome after one year was deter-
mined according to Engel’s classification.10Results
Study group
The study group included 42 patients (20 males)
with a mean age of 27 (7—50) years, who had
suffered from drug resistant epilepsies for 2—42
years. Forty patients were studied with 1.5, two
patients with 3 Tesla systems.Table 1 Lesion categories, discordant MRI diagnoses, and
Lesion category n
Epilepsy-associated tumours 13





a MRI: One ganglioglioma was diagnosed instead of an ANET (see Fig
(see Figure 2), One FCD instead of a ganglioglioma.
b MRI: One FCD was diagnosed instead of a mMCD (see Figure 3).
c MRI: One cavernoma was diagnosed instead of an AVM, 1 SturgeMRI, histopathology, and postsurgical
outcome (Table 1)
With respect to the histopathological diagnoses
we divided the lesions into the following
categories(Table 1):1. Eseiz
ure
-Wepilepsy-associated tumors (n = 13)
Five gangliogliomas and five dysembryoplastic
neuroepithelial tumours (DNTs) were diagnosed
correctly. One ganglioglioma was misclassified on
MRI as focal cortical dysplasia. One ‘‘MRI gang-
lioglioma’’ each was histopathologically classi-
fied as angiocentric neuroepithelial tumour
(ANET) (Fig. 1) and isomorphic astrocytoma
(IA) (Fig. 2), respectively. Both are new entities,
which have been described recently.11—14 Seizure
outcome was excellent (Engel class I) in eight
patients (62%).2. Focal cortical dysplasias (FCDs) (n = 16)
According to the classification of Palmini and
Lu¨ders there were 14 FCDs with balloon cells
(FCD IIb), one FCDs without ballon cells (FCD
IIa), and onemild malformation of cortical devel-
opment (mMCD).15,16 On MRI, we described 11
FCD IIb and 5 FCDwithout further classification as
these lesions lacked the subcortical hyperinten-
sity tapering towards the lateral ventricle sug-
gestive of FCD IIb.17 One FCD diagnosed by MRI
was histopathologically classified as mMCD,
which seems debatable since it was a circum-
scribed cortical signal hyperintensity and not
only a blurring of the grey/white matter inter-
face (Fig. 3). One year following surgery, 11
patients (69%) were seizure free (Engel class I).3. Vascular malformations (n = 4)
While two cavernomas were diagnosed cor-
rectly, one small lesion was considered to be a
cavernoma on MRI but histopathologically classi-
fied as arterio-venous malformation (AVM). One










1), One ganglioglioma instead of an isomorphic astrocytoma
ber angiomatosis instead of an unknown lesion.
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Figure 1 Angiocentric neuroepithelial tumour (ANET). Axial 5 mm thick FLAIR (A), T2-weighted TSE (B), T1-weighted SE
(C), contrast enhanced T1-weighted SE (D), coronal 5 mm thick IR (E), and 2 mm thick T2-weighted TSE images. Note a
cortical and subcortical lesion within the left cuneus with a cystic component in its centre. The cortex is hyperintense on
unenhanced T1-weighted images (arrow in D), the lesion does not enhance GD-DTPA (E).without a clear MRI diagnosis was considered to
represent a circumscribed Sturge Weber angio-
matosis although the patient had no (trigeminal)
nevus flammeus. This patient and both patients
with cavernomas were seizure free one year
following surgery (75%).4. Gyral scars (n = 6)
Six gyral scars were diagnosed correctly.
Three of the six (50%) patients achieved seizure
freeness one year following surgery. Initially, one
scar was histopathologically considered as FCD
IIa. Since MRI signal changes remote from the
resected lesion itself indicated a more wide-
spread and rather destructive process (Fig. 4),
extended immunohistochemical investigations
with antibodies against NeuN, synaptophysin,
glial fibrillary acidic protein and CD68 were per-
formed in additional tissue specimens of the
lesion, which was re-classified as gyral scar.5. Other
One HIV-negative African womanwith a history
of seizures for three years had a contrast-enhan-
cing cortical lesion along the left intraparietal
sulcus surrounded by a large oedema which was
suspicious on an infection and correctly classifiedas tuberculosis. She did not become seizure free
following operation and drug therapy.6. No lesion
Two patients without lesions on MRI were oper-
ated on electrophysiological basis, only. Both spe-
cimens were histopathologically unrevealing, and
none of the patients became seizure free.Discussion
This series of patients with drug-resistant parietal
and occipital lobe epilepsies shows a high concor-
dance (86%) betweenMRI and histopathological diag-
noses: Within the category epilepsy-associated
tumors all five DNTs were diagnosed correctly. One
lesion was considered a FCD on MRI but histopatho-
logically represented a ganglioglioma. If MRI lesions
do not have intracortical cysts and do not enhance
Gd-DTPA it is difficult to distinguish both entities.
Histopathologically, a ganglioglioma is sometimes
surroundedbydysplastic cortex.Moreover, both enti-
ties have common moleculargenetic alterations
(increased incidence of polymorphisms in TSC2 gene)
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Figure 2 Isomorphic astrocytoma. Sagittal 1 mm thick 3D-T1-weighted MDEFT (A), axial 5 mm thick contrast enhanced
T1-weighted SE (C), and T2-weighted TSE (E) images, coronal 5 mm thick IR images (D). Note a homogenous lesion in the
left cuneus which is predominantly located in the subcortical white matter. The lesion is relatively hypointense on T1-
weighted and hyperintense on FLAIR and T2-weighted images. It does not enhance GD-DTPA (C).andaFCD is sometimesconsideredasprecursor lesion
of a ganglioglioma.18 Accordingly, Barkovich et al.
consider DNTs and gangliogliomas as neoplastic
lesions within the category ‘‘malformations due to
abnormalneuronal andglial proliferations’’.19Two
lesions were considered as gangliogliomas while the
neuropathologist classified themas angiocentric neu-
roepithelial tumour (ANET) and isomorphic astrocy-
toma, respectively. The ANET is a recently described
epilepsy associated tumor (together 18 cases) with
histopathological features of infiltrating astrocytoma
and ependymoma. It has a specific MR imaging
appearance consisting of a cortical/subcortical loca-
tion, a handle-like extention towards the lateral
ventricle and a ribbon-like cortical hyperintensity
on T1-weighted images. The tumor is hyperintense
on T2-weighted images, has no calcifications, and
does not enhance Gd-DTPA.11,12 The isomorphic
astrocytoma (around 20 cases known so far) is an
infiltrating tumour with a low cellularity and ‘‘no’’
mitoses. Accordingly, it is relatively hypointense on
T1-weighted and hyperintense on T2-weighted
images. The cortical/subcortical tumor has no calci-
fications and does not enhance Gd-DTPA.13,14 Within
the category focal cortical dysplasias, 11 FCD IIbexhibited a typical MR imaging appearance consisting
of amild cortical hyperintensity andadistinct funnel-
shaped subcortical hyperintensity tapering towards
the lateral ventricle.17 In three FCD IIb a mild sub-
cortical hyperintensity was less apparent. One lesion
was histopathologically classified as FCD IIa, one as
mMCD. On MRI, both lesions showed a circumscribed
cortical hyperintensity on FLAIR sequences indicating
that the correlation between histopathology and MRI
is not close.
Among the vascular malformations two caverno-
mas with signal characteristics indicating loculated
areas of hemorrhage and thrombosis of varying age
surrounded by areas of hemosiderin-stained brain
were easily appreciated on T2-weighted images.
Another lesion with a diameter of 1 cm had the
same signal characteristics, no tubular flow void
structures were seen in the vicinity. Whether the
occipital atrophic and calcified lesion truly repre-
sents a Sturge-Weber angiomatosis remains unclear:
The association of occipital calcifications and epi-
lepsy has been described by numerous authors, and
up to 77% of patients with this picture have celiac
disease.20—23 However, in contrast to our case, cal-
cifications are usually bilateral, and there is no
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Figure 3 Axial 5 mm thick (A) and coronal 3 mm thick (B) FLAIR TSE images show a circumscribed cortical hyperintensity
without subcortical signal alterations (arrow). These MRI findings are compatible with a FCD IIa but untypical for anmMCD
in which blurring of the grey/white matter interface is a usual finding. Note also that this lesion was overlooked nine years
ago when the patient underwent right-sided selective amygdalohippocampectomy due to a presumed seizure onset zone
in the right hippocampus (hollow arrow in A).atrophy and no contrast enhancement.23 Our
patient had no apparent celiac disease but whether
patients with occipital calcification and without
apparent celiac disease are carriers of a latent form
of the disease is also a matter of debate.23
Gyral scars are typically recognized due to a
focally widened subarachnoid space and a hyperin-
tense and atrophic cortex on long TR/long TE
sequences. Due to nulling of the CSF signal, this
pattern is best appreciated on FLAIR MRI perpendi-
cular to the brain surface. In this series, one lesion
with this pattern was initially considered as FCD IIa.Figure 4 Coronal 3 mm thick FLAIR TSE images show an occip
as FCD IIa (arrow). The atrophic and hyperintense cortex also
widespread process with gyral scarring (hollow arrow). Extende
gyral scar.However, since MRI showed atrophic and on FLAIR
sequences hyperintense cortex remote from the
resected tissue itself, further immunohistochemical
investigations were performed in extended portions
of the lesion, which was re-classified as gyral scar.
There are several papers about parietal and occi-
pital lobe epilepsies in the literature, that mainly
focus on seizure semiology, the localizing value of
different imaging modalities, and seizure out-
come.1,3,4,24—31 The proportion of developmental
lesions (malformations of cortical development,
cortical dysplasias), epilepsy-associated tumors,ital lesion which was initially histopathologically classified
above the parieto-occipital fissure is suggestive of a more
d immunohistochemical investigations led to the diagnosis
614 H. Urbach et al.vascular lesions, and ‘‘defects’’ (scarring, trauma) is
similar to our series,28,29 the proportion of seizure
free patients higher for patients with epilepsy asso-
ciated tumours than developmental abnormal-
ities.26,30,31 However, new (neuropathological)
classification schemes and tumor entities as well as
advances in MRI make a direct comparison between
these series of the late 1990s and ours difficult.
If we consider these advances during the past
years (e.g. 3 Tesla scanners) and the debatable cases
in this series (see Figs. 3 and 4), we believe that
characterization of epileptogenic lesions has to rely
on both, MRI and histopathology.References
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